Symphony Q1 FY27 Earnings Call — Analysis (NSE: SYMPHONY)

Symphony posts 8% consolidated revenue growth and 26% EBITDA jump in Q1FY27, driven by domestic momentum and a turnaround in US/China subsidiaries, while Australia remains a drag.

11 Aug 2026 · Analysis by Alpha Inflection

Result quality: stable — Steady quarter. Management sentiment: neutral.

The take

Q1FY27 Consolidated Revenue ₹378 Cr ( +8% YoY ) . New story: Diversification beyond Indian summer .

Results

Consolidated revenue ₹378 Cr (+8% YoY), EBITDA ₹48 Cr (+26% YoY), reported PAT ₹40 Cr (-5% YoY); adjusted for one‑time items, EBITDA ₹53 Cr and PAT ₹43 Cr (up 23% YoY).

Financial highlights

Guidance

Management warned of near-term margin pressure from elevated raw material costs, indicated price hikes are planned in the household cooler segment, and expects significant sales growth in Mexico and the US next summer if weather normalizes, but issued no numerical guidance.

What management committed to

• In the short term, [Symphony’s] margins are likely to be impacted [by elevated raw material costs], despite passing on some cost increases to the market and pursuing value engineering. — in the short term
• Symphony will take price hikes in the household cooler segment in the coming days. — Q2FY27
• Symphony will not deploy any additional capital in its Australian business and there will be no further impairment or write‑offs. — ongoing
• Statistically, a third consecutive mild summer in Mexico is almost impossible; therefore, [IMPCO Mexico] sales should grow significantly in the summer of 2027. — Q1FY28
• If the summer is robust, [Bonaire USA] sales should further increase next summer (2027). — Q1FY28
• Modern trade growth rates of over 100% that Symphony experienced are very unlikely to be sustained going forward. — going forward
• With inventory normalized, general trade and all other trade channels should register growth in the coming periods. — coming periods

Key themes

Diversification beyond Indian summer and margin resilience

How the narrative shifted

• Diversification beyond Indian summer: Management highlights that 48% of consolidated TTM revenue now comes from BISP products and overseas subsidiaries, permanently reducing reliance on the Indian summer season.
• Raw material cost headwinds: Elevated plastic and other input costs, exacerbated by geopolitical tensions, are creating near-term margin pressure despite partial price pass-throughs and cost reduction efforts.
• International portfolio rebalancing: US and China subsidiaries turn around strongly, while Mexico awaits weather recovery; Australia is ring-fenced with a capital freeze to contain losses.
• Channel mix transformation: Surge in modern trade and digital/D2C channels (profitable and scalable) as general trade absorps prior-year inventory, driving a structural shift in sales mix.
• Weather dependency remains high: Despite diversification, management’s outlook for key markets like Mexico and the US is explicitly conditioned on a return to normal or strong summer weather.
• Capital discipline and balance-sheet strength: Symphony reduced its capital employed, maintains a large treasury, and capped commitments to loss-making subsidiaries, signaling prudent capital stewardship.

Operational commentary

• BISP (Beyond India Summer Products) share reached 48% of consolidated trailing‑twelve‑month revenue, reinforcing diversification away from Indian summer dependency.
• Bonaire USA revenue grew 35% YoY with robust profitability, driven by successful scale‑up of new air cooler models (especially the ‘Air Force’ model) and a hot summer in the Southwest US.
• GSK China revenue grew 43% YoY; operating leverage lifted profitability, and the subsidiary became completely debt-free after repaying its loan and interest to Symphony India.
• Domestic India revenue rose 15% despite heavy channel inventory carried over from a poor summer in 2025; inventory at both trade and company level was fully normalized by quarter-end.
• Modern trade (>100% YoY growth) and digital/D2C channels recorded highly profitable growth, aided by very low channel inventory; management indicated such high growth rates are unlikely to sustain.
• Standalone exports declined due to geopolitical and shipping disruptions; landed costs rose significantly, muting buyer sentiment, with the Middle East region still affected.
• CTPL Australia revenue softened further; management stated there will be no additional capital allocation and that impairment/write‑offs are fully behind.
• Interim dividend of ₹1 per share declared for the quarter; total payout approx. ₹7 Cr.
• Standalone core capital employed rationalized to ₹73 Cr, translating into ROCE of 164%; treasury stood at ₹345 Cr after repaying ~₹225 Cr for Australian subsidiary obligations.

Analyst Q&A

• Q. What drove the >100% growth in modern trade and is it sustainable?

  Achal Bakeri explained it was largely due to very low channel inventory in modern trade compared to general trade, which was still carrying heavy inventory from the previous year. He stated that similar growth rates are very unlikely to be repeated going forward, and that as inventory has normalized, general trade and other channels should now register growth.

• Q. Could you share the revenue, EBITDA and PAT numbers for each subsidiary?

  Nrupesh Shah provided detailed figures for Bonaire USA (rev ₹36 Cr, EBITDA ₹18 Cr, PAT ₹17 Cr), IMPCO Mexico (₹54 Cr, ₹3 Cr, ₹1 Cr), GSK China (₹34 Cr, ₹6 Cr, ₹5 Cr) and CTPL Australia (₹27 Cr, EBITDA -₹4 Cr, reported PAT ₹36 Cr due to one-time gain, operating loss).

• Q. What price hikes have been implemented and what further hikes are planned?

  Achal Bakeri stated that no price hikes have been taken in the household cooler segment so far; in other segments, 7‑10% increases have been implemented. He confirmed that price hikes in household coolers will be taken ‘in the days to come’, but the extent will depend on how long raw material costs remain elevated.

• Q. What is the strategy to turn around the Australian subsidiary, given its persistent challenges?

  Nrupesh Shah said the clear strategy is not to deploy any additional capital and to do whatever possible without fresh investment; he assured no further impairment or write‑offs. Achal Bakeri added that there are no new products or distribution changes — ‘just more of the same, nothing new.’

View source

Research and educational content only. Not investment advice.